RELATED CONTENT
NEWS
- Betanis, Tradjenta and Onbrez priced and set for launch in Japan
- ARISTOTLE: changing thinking about BMS/Pfizer's Eliquis in anticoagulation?
- Positive Phase III data for LifeCycle's 'improved Prograf' despite higher drop-out
- BMS and Sanofi mentioned in $1bn deal speculation over Biocon's oral insulin

